Quantumimplant.com

The timeline behind quantumimplant.com

Registration, the decision and the archived record of what this domain actually displayed — from public RDAP and the Internet Archive.

Result of record. The panel's reasoning and decisive facts behind each element are in the Intelligence dossier below.

NATIONAL ARBITRATION FORUM DECISION Quantum Bioengineering, Ltd. v. Bicon Korea Corp. Claim Number: FA0710001094612 PARTIES Complainant is Quantum Bioengineering, Ltd. (“Complainant”), represented by Jesus Sanchelima, of Sanchelima & Associates, P.A., 235 S.W. Le Jeune Road, Miami, FL 33134-1762. Respondent is Bicon Korea Corp (“Respondent”), #202 Sanmok Bldg 132-4, Chongdam-dong Kangnam-gu, Seoul 135100, KR. REGISTRAR AND DISPUTED DOMAIN NAME The domain name at issue is <quantumimplant.com>, registered with Yesnic Co. Ltd. PANEL The undersigned certifies that he or she has acted independently and impartially and to the best of his or her knowledge has no known conflict in serving as Panelist in this proceeding. Sandra J. Franklin as Panelist. PROCEDURAL HISTORY Complainant submitted a Complaint to the National Arbitration Forum electronically on October 17, 2007; the National Arbitration Forum received a hard copy of the Complaint on October 17, 2007. The Complaint was submitted in both Korean and English. On October 21, 2007, Yesnic Co. Ltd. confirmed by e-mail to the National Arbitration Forum that the <quantumimplant.com> domain name is registered with Yesnic Co. Ltd. and that Respondent is the current registrant of the name. Yesnic Co. Ltd. has verified that Respondent is bound by the Yesnic Co. Ltd. registration agreement and has thereby agreed to resolve domain-name disputes brought by third parties in accordance with ICANN's Uniform Domain Name Dispute Resolution Policy (the "Policy"). On October 31, 2007, a Korean language Notification of Complaint and Commencement of Administrative Proceeding (the "Commencement Notification"), setting a deadline of November 20, 2007 by which Respondent could file a response to the Complaint, was transmitted to Respondent via e-mail, post and fax, to all entities and persons listed on Respondent's registration as technical, administrative and billing contacts, and to postmaster@quantumimplant.com by e-mail. Having received no response from Respondent, the National Arbitration Forum transmitted to the parties a Notification of Respondent Default. On November 27, 2007, pursuant to Complainant's request to have the dispute decided by a single-member Panel, the National Arbitration Forum appointed Sandra J. Franklin as Panelist. Having reviewed the communications records, the Administrative Panel (the "Panel") finds that the National Arbitration Forum has discharged its responsibility under Paragraph 2(a) of the Rules for Uniform Domain Name Dispute Resolution Policy (the "Rules") "to employ reasonably available means calculated to achieve actual notice to Respondent." Therefore, the Panel may issue its decision based on the documents submitted and in accordance with the ICANN Policy, ICANN Rules, the National Arbitration Forum's Supplemental Rules and any rules and principles of law that the Panel deems applicable, without the benefit of any response from Respondent. Pursuant to Rule 11(a) the Panel determines that the language requirement has been satisfied through the Korean language Complaint and Commencement Notification and, absent a Response, determines that the remainder of the proceedings may be conducted in English. RELIEF SOUGHT Complainant requests that the domain name be transferred from Respondent to Complainant. PARTIES' CONTENTIONS A. Complainant makes the following assertions: 1. Respondent’s <quantumimplant.com> domain name is confusingly similar to Complainant’s QUANTUM mark. 2. Respondent does not have any rights or legitimate interests in the <quantumimplant.com> domain name. 3. Respondent registered and used the <quantumimplant.com> domain name in bad faith. B. Respondent failed to submit a Response in this proceeding. FINDINGS Complainant, Quantum Bioengineering, Ltd., manufactures dental implants. Complainant has used the QUANTUM mark for dentistry implants since as early as May 1, 1999. Complainant holds a trademark registration with the United States Patent and Trademark Office (“USPTO”) for QUANTUM (Reg. No. 2,750,690, issued August 12, 2003). Respondent registered the < quantumimplant.com> domain name on January 2, 2004. DISCUSSION Paragraph 15(a) of the Rules instructs this Panel to "decide a complaint on the basis of the statements and documents submitted in accordance with the Policy, these Rules and any rules and principles of law that it deems applicable." In view of Respondent's failure to submit a response, the Panel shall decide this administrative proceeding on the basis of Complainant's undisputed representations pursuant to paragraphs 5(e), 14(a) and 15(a) of the Rules and draw such inferences it considers appropriate pursuant to paragraph 14(b) of the Rules. The Panel is entitled to accept all reasonable allegations and inferences set forth in the Complaint as true unless the evidence is clearly contradictory. See Vertical Solutions Mgmt., Inc. v. webnet-marketing, inc., FA 95095 (Nat. Arb. Forum July 31, 2000) (holding that the respondent’s failure to respond allows all reasonable inferences of fact in the allegations of the complaint to be deemed true); see also Talk City, Inc. v. Robertson, D2000-0009 (WIPO Feb. 29, 2000) (“In the absence of a response, it is appropriate to accept as true all allegations of the Complaint.”). Paragraph 4(a) of the Policy requires that Complainant must prove each of the following three elements to obtain an order that a domain name should be cancelled or transferred: (1) the domain name registered by Respondent is identical or confusingly similar to a trademark or service mark in which Complainant has rights; and (2) Respondent has no rights or legitimate interests in respect of the domain name; and (3) the domain name has been registered and is being used in bad faith. Identical and/or Confusingly Similar Complainant has established rights in the QUANTUM mark. Complainant owns a trademark registration with the USPTO. The Panel finds that where Complainant has submitted evidence of a valid trademark registration, Policy ¶ 4(a)(i) has been satisfied. See Lockheed Martin Corp. v. Hoffman, FA 874152 (Nat. Arb. Forum Jan. 31, 2007) (finding that the complainant had sufficiently established rights in the SKUNK WORKS mark through its registration with the USPTO); see also Trip Network Inc. v. Alviera, FA 914943 (Nat. Arb. Forum Mar. 27, 2007) (finding that the complainant’s federal trademark registrations for the CHEAPTICKETS and CHEAPTICKETS.COM marks were adequate to establish its rights in the mark pursuant to Policy ¶ 4(a)(i)). Respondent’s <quantumimplant.com> domain name is confusingly similar to Complainant’s mark. Respondent’s domain name contains Complainant’s entire QUANTUM mark and adds the generic term “implant”, which describes goods offered under Complainant’s mark, along with the generic top-level domain (“gTLD”) “.com.” The Panel finds that Respondent’s additions to an otherwise unchanged mark fail to distinguish Respondent’s domain name from Complainant’s mark in any meaningful way for purposes of Policy ¶ 4(a)(i). See Brown & Bigelow, Inc. v. Rodela, FA 96466 (Nat. Arb. Forum Mar. 5, 2001) (finding that the <hoylecasino.net> domain name is confusingly similar to the complainant’s HOYLE mark, and that the addition of “casino,” a generic word describing the type of business in which the complainant is engaged, does not take the disputed domain name out of the realm of confusing similarity); see also Am. Int’l Group, Inc. v. Ling Shun Shing, FA 206399 (Nat. Arb. Forum Dec. 15, 2003) (finding that the addition of the term “assurance,” to the complainant’s AIG mark failed to sufficiently differentiate the name from the mark under Policy ¶ 4(a)(i) because the appended term related directly to the complainant’s business); see also Trip Network Inc. v. Alviera, FA 914943 (Nat. Arb. Forum Mar. 27, 2007) (concluding that the addition of a gTLD, whether it be “.com,” “.net,” “.biz,” or “.org,” is irrelevant to a Policy ¶ 4(a)(i) analysis). The Panel finds that Policy ¶ 4(a)(i) has been satisfied. Rights or Legitimate Interests/ Registration and Use in Bad Faith While Complainant has alleged that Respondent does not have rights or legitimate interests in the <quantumimplant.com> domain name, Complainant has failed to allege Respondent’s use of the domain name and has failed to set forth sufficient evidence of bad faith registration and use. Complainant merely restates the Policy language in its Complaint and little else. The Panel finds that without any knowledge of Respondent’s use, the Panel has no choice but to deny Complainant’s claim. See <quantumimplant.com> domain name; see also Claessens Prod. Consultants BV v. Claessens Int’l Ltd., FA 238656 (Nat. Arb. Forum Apr. 23, 2004) (finding that Complainant failed to meet its burden pursuant to Policy ¶ 4(a)(ii) where Complainant neglected to state how Respondent used the disputed domain name in the Complaint). DECISION Having failed to establish all three elements required under the ICANN Policy, the Panel concludes that relief shall be DENIED. Sandra J. Franklin, Panelist Dated: December 7, 2007 Click Here to return to the main Domain Decisions Page. Click Here to return to our Home Page NATIONAL ARBITRATION FORUM

Source of record: FORUM . Reproduced for research; FORUM is the authoritative source.